Intech Investment Management LLC acquired a new position in shares of Nu Skin Enterprises, Inc. (NYSE:NUS – Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 18,689 shares of the company’s stock, valued at approximately $138,000.
A number of other hedge funds and other institutional investors have also bought and sold shares of NUS. Price T Rowe Associates Inc. MD grew its position in Nu Skin Enterprises by 16.8% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 45,156 shares of the company’s stock worth $625,000 after acquiring an additional 6,502 shares during the last quarter. GAMMA Investing LLC grew its position in Nu Skin Enterprises by 167.4% during the 2nd quarter. GAMMA Investing LLC now owns 5,734 shares of the company’s stock worth $60,000 after acquiring an additional 3,590 shares during the last quarter. SummerHaven Investment Management LLC grew its position in shares of Nu Skin Enterprises by 4.7% in the 2nd quarter. SummerHaven Investment Management LLC now owns 25,778 shares of the company’s stock valued at $272,000 after buying an additional 1,152 shares during the last quarter. Bank of New York Mellon Corp grew its position in shares of Nu Skin Enterprises by 5.1% in the 2nd quarter. Bank of New York Mellon Corp now owns 901,098 shares of the company’s stock valued at $9,498,000 after buying an additional 43,935 shares during the last quarter. Finally, Signaturefd LLC grew its position in shares of Nu Skin Enterprises by 72.6% in the 2nd quarter. Signaturefd LLC now owns 3,797 shares of the company’s stock valued at $40,000 after buying an additional 1,597 shares during the last quarter. Institutional investors own 82.84% of the company’s stock.
Nu Skin Enterprises Stock Down 2.5 %
Shares of Nu Skin Enterprises stock opened at $7.50 on Friday. Nu Skin Enterprises, Inc. has a one year low of $5.95 and a one year high of $20.75. The company has a debt-to-equity ratio of 0.53, a current ratio of 1.93 and a quick ratio of 1.20. The stock’s 50-day moving average is $6.83 and its 200 day moving average is $9.13. The firm has a market cap of $372.83 million, a price-to-earnings ratio of -3.62 and a beta of 1.20.
Nu Skin Enterprises Announces Dividend
Analyst Ratings Changes
A number of equities research analysts have commented on NUS shares. DA Davidson reduced their price target on Nu Skin Enterprises from $12.50 to $11.00 and set a “neutral” rating on the stock in a research report on Monday, August 12th. StockNews.com upgraded Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research report on Monday, November 11th. Finally, Citigroup reduced their price target on Nu Skin Enterprises from $11.50 to $6.75 and set a “neutral” rating on the stock in a research report on Tuesday, October 22nd.
Nu Skin Enterprises Profile
Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.
Featured Articles
- Five stocks we like better than Nu Skin Enterprises
- How to Buy Cheap Stocks Step by Step
- Fast-Growing Companies That Are Still Undervalued
- 3 Small Caps With Big Return Potential
- Top Cybersecurity Stock Picks for 2025
- How to Effectively Use the MarketBeat Ratings Screener
- Archer or Joby: Which Aviation Company Might Rise Fastest?
Want to see what other hedge funds are holding NUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nu Skin Enterprises, Inc. (NYSE:NUS – Free Report).
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.